FI921598L - Transdermal komposition - Google Patents
Transdermal komposition Download PDFInfo
- Publication number
- FI921598L FI921598L FI921598A FI921598A FI921598L FI 921598 L FI921598 L FI 921598L FI 921598 A FI921598 A FI 921598A FI 921598 A FI921598 A FI 921598A FI 921598 L FI921598 L FI 921598L
- Authority
- FI
- Finland
- Prior art keywords
- transdermal composition
- transdermal
- composition
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/86—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB919108357A GB9108357D0 (en) | 1991-04-18 | 1991-04-18 | Heterocyclic amides |
| GB919108358A GB9108358D0 (en) | 1991-04-18 | 1991-04-18 | Heterocyclic compounds |
| GB929205392A GB9205392D0 (en) | 1992-03-12 | 1992-03-12 | Heterocyclic amides |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI921598A0 FI921598A0 (fi) | 1992-04-10 |
| FI921598A7 FI921598A7 (fi) | 1992-10-19 |
| FI921598L true FI921598L (fi) | 1992-10-19 |
Family
ID=27265602
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI921598A FI921598L (fi) | 1991-04-18 | 1992-04-10 | Transdermal komposition |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP0509769B1 (fi) |
| JP (1) | JPH0656785A (fi) |
| KR (1) | KR920019750A (fi) |
| AU (1) | AU660664B2 (fi) |
| CA (1) | CA2065794A1 (fi) |
| CS (1) | CS117692A3 (fi) |
| DE (1) | DE69213537T2 (fi) |
| FI (1) | FI921598L (fi) |
| GB (1) | GB9207145D0 (fi) |
| HU (1) | HUT66541A (fi) |
| IE (1) | IE921159A1 (fi) |
| IL (1) | IL101555A0 (fi) |
| NO (1) | NO921451L (fi) |
| NZ (1) | NZ242322A (fi) |
| TW (1) | TW262475B (fi) |
Families Citing this family (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5521179A (en) * | 1991-04-18 | 1996-05-28 | Zeneca Limited | Heterocyclic amides |
| US5486529A (en) * | 1992-04-16 | 1996-01-23 | Zeneca Limited | Certain pyridyl ketones for treating diseases involving leukocyte elastase |
| GB9307555D0 (en) * | 1992-04-16 | 1993-06-02 | Zeneca Ltd | Heterocyclic compounds |
| US5441960A (en) * | 1992-04-16 | 1995-08-15 | Zeneca Limited | 1-pyrimidinylacetamide human leukocyte elastate inhibitors |
| AU4077193A (en) * | 1992-04-16 | 1993-11-18 | Zeneca Limited | Alpha-aminoboronic acid peptides and their use as elastase inhibitors |
| EP0636143B1 (en) * | 1992-04-16 | 1997-09-24 | Zeneca Limited | Alpha-aminoboronic acid peptides and their use as elastase inhibitors |
| GB9211783D0 (en) * | 1992-06-04 | 1992-07-15 | Ici Plc | Amide derivatives |
| GB9214053D0 (en) * | 1992-07-02 | 1992-08-12 | Ici Plc | Heterocyclic amides |
| US6608204B1 (en) * | 1994-12-13 | 2003-08-19 | Corvas International, Inc. | Aromatic heterocyclic derivatives as enzyme inhibitors |
| US5656645A (en) * | 1994-12-13 | 1997-08-12 | Corvas International, Inc. | Aromatic heterocyclic derivatives as enzyme inhibitors |
| US5658930A (en) * | 1994-12-13 | 1997-08-19 | Corvas International, Inc. | Aromatic heterocyclic derivatives as enzyme inhibitors |
| EP0826671B1 (en) * | 1995-04-27 | 2004-12-29 | Mitsubishi Pharma Corporation | Heterocyclic amide compounds and medicinal use of the same |
| WO1997001338A1 (en) * | 1995-06-27 | 1997-01-16 | Merck & Co., Inc. | Pyridinone-thrombin inhibitors |
| US5668289A (en) * | 1996-06-24 | 1997-09-16 | Merck & Co., Inc. | Pyridinone thrombin inhibitors |
| US5872138A (en) * | 1996-09-13 | 1999-02-16 | Merck & Co., Inc. | Thrombin inhibitors |
| US5869487A (en) * | 1996-10-24 | 1999-02-09 | Merck & Co., Inc. | Pyrido 3,4-B!pyrazines for use as thrombin inhibitors |
| WO1998018794A1 (en) * | 1996-10-25 | 1998-05-07 | Yoshitomi Pharmaceutical Industries, Ltd. | Novel heterocyclic amide compounds and medicinal uses thereof |
| US6017934A (en) * | 1997-01-22 | 2000-01-25 | Merck & Co., Inc. | Thrombin inhibitors |
| US5792779A (en) * | 1997-02-19 | 1998-08-11 | Merck & Co., Inc. | Pyridinone thrombin inhibitors |
| US6011038A (en) * | 1997-09-05 | 2000-01-04 | Merck & Co., Inc. | Pyrazinone thrombin inhibitors |
| US6087373A (en) * | 1997-09-23 | 2000-07-11 | Merck & Co., Inc. | Thrombin inhibitors |
| US6133297A (en) * | 1997-09-30 | 2000-10-17 | Merck & Co., Inc. | Thrombin inhibitors |
| CN1550232A (zh) * | 1998-03-11 | 2004-12-01 | 杂环酰胺化合物在制备自身免疫性疾病抑制剂中的用途 | |
| US6147078A (en) * | 1998-05-19 | 2000-11-14 | Merck & Co., Inc. | Pyrazinone thrombin inhibitors |
| EP1117660A4 (en) * | 1998-09-28 | 2002-01-09 | Merck & Co Inc | Thrombin Inhibitors |
| CA2348530A1 (en) | 1998-10-30 | 2000-05-11 | Merck & Co., Inc. | Thrombin inhibitors |
| AU747776B2 (en) | 1998-10-30 | 2002-05-23 | Merck & Co., Inc. | Thrombin inhibitors |
| US6239132B1 (en) | 1999-04-23 | 2001-05-29 | Merck & Co., Inc. | Thrombin inhibitors |
| UA58636C2 (uk) | 1999-06-04 | 2003-08-15 | Мерк Енд Ко., Інк. | Піразинонові інгібітори тромбіну, фармацевтична композиція, спосіб інгібування утворення тромбів у крові, спосіб лікування станів, пов'язаних із тромбоутворенням |
| WO2000074682A1 (en) | 1999-06-04 | 2000-12-14 | Merck & Co., Inc. | Thrombin inhibitors |
| WO2001038323A1 (en) | 1999-11-23 | 2001-05-31 | Merck & Co., Inc. | Pyrazinone thrombin inhibitors |
| EP1267876A1 (en) | 2000-03-23 | 2003-01-02 | Merck & Co., Inc. | Thrombin inhibitors |
| TW200500341A (en) * | 2002-11-12 | 2005-01-01 | Astrazeneca Ab | Novel compounds |
| PE20050159A1 (es) * | 2003-05-27 | 2005-04-19 | Vertex Pharma | Derivados de acido 3-[2-(3-amino-2-oxo-2h-piridin-1-il)-acetilamino]-4-oxo-pentanoico como inhibidores de caspasa |
| SE0302487D0 (sv) * | 2003-09-18 | 2003-09-18 | Astrazeneca Ab | Novel compounds |
| ATE543803T1 (de) | 2004-11-24 | 2012-02-15 | Vertex Pharma | 3-ä2-(3-azylamino-2-oxo-2h-pyridin-1- yl)acetylaminoü-4-oxopentansäurederivate und deren verwendung als caspase-inhibitoren |
| CA2610400A1 (en) * | 2005-06-07 | 2006-12-14 | Pharmacopeia, Inc. | Azinone and diazinone v3 inhibitors for depression and stress disorders |
| KR20080022092A (ko) * | 2005-06-08 | 2008-03-10 | 노파르티스 아게 | 유기 화합물 |
| CN110950807B (zh) * | 2018-09-26 | 2023-03-03 | 中国科学院上海药物研究所 | 联芳基类化合物、其制备方法、药物组合物及其应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4474778A (en) * | 1983-11-09 | 1984-10-02 | E. R. Squibb & Sons, Inc. | Lactam containing compounds, their pharmaceutical compositions and method of use |
| GB8600263D0 (en) * | 1985-01-22 | 1986-02-12 | Ici America Inc | Peptide derivatives |
-
1992
- 1992-04-01 GB GB929207145A patent/GB9207145D0/en active Pending
- 1992-04-10 IE IE115992A patent/IE921159A1/en unknown
- 1992-04-10 CA CA002065794A patent/CA2065794A1/en not_active Abandoned
- 1992-04-10 NZ NZ242322A patent/NZ242322A/en unknown
- 1992-04-10 FI FI921598A patent/FI921598L/fi not_active Application Discontinuation
- 1992-04-10 KR KR1019920006072A patent/KR920019750A/ko not_active Withdrawn
- 1992-04-10 IL IL101555A patent/IL101555A0/xx unknown
- 1992-04-10 HU HU9201225A patent/HUT66541A/hu unknown
- 1992-04-10 AU AU14827/92A patent/AU660664B2/en not_active Ceased
- 1992-04-10 NO NO92921451A patent/NO921451L/no unknown
- 1992-04-15 EP EP92303358A patent/EP0509769B1/en not_active Expired - Lifetime
- 1992-04-15 DE DE69213537T patent/DE69213537T2/de not_active Expired - Fee Related
- 1992-04-16 CS CS921176A patent/CS117692A3/cs unknown
- 1992-04-18 JP JP4143140A patent/JPH0656785A/ja active Pending
- 1992-04-29 TW TW081103383A patent/TW262475B/zh active
Also Published As
| Publication number | Publication date |
|---|---|
| DE69213537T2 (de) | 1997-02-20 |
| FI921598A7 (fi) | 1992-10-19 |
| EP0509769A3 (en) | 1993-09-01 |
| IE921159A1 (en) | 1992-10-21 |
| CS117692A3 (en) | 1992-11-18 |
| FI921598A0 (fi) | 1992-04-10 |
| HUT66541A (en) | 1994-12-28 |
| KR920019750A (ko) | 1992-11-19 |
| TW262475B (en) | 1995-11-11 |
| AU1482792A (en) | 1992-10-22 |
| AU660664B2 (en) | 1995-07-06 |
| DE69213537D1 (de) | 1996-10-17 |
| JPH0656785A (ja) | 1994-03-01 |
| NO921451L (no) | 1992-10-19 |
| NZ242322A (en) | 1994-12-22 |
| EP0509769B1 (en) | 1996-09-11 |
| IL101555A0 (en) | 1992-12-30 |
| NO921451D0 (no) | 1992-04-10 |
| CA2065794A1 (en) | 1992-10-19 |
| HU9201225D0 (en) | 1992-07-28 |
| GB9207145D0 (en) | 1992-05-13 |
| EP0509769A2 (en) | 1992-10-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI921598L (fi) | Transdermal komposition | |
| DE69218302D1 (de) | Betonzusammensetzung | |
| BR9205430A (pt) | Composicao adesiva | |
| FI925727A0 (fi) | Transdermal dosering av burprenorfin | |
| FI931738L (fi) | Teknisk harts-propenymppolymerkomposition | |
| DE69325158D1 (de) | Photokromische Zusammensetzung | |
| DE69431209D1 (de) | Transdermale prostaglandin-zusammensetzung | |
| DE69222234D1 (de) | Photopolymerisierbare Zusammensetzung | |
| BR8905204A (pt) | Composicao colutoria | |
| FI933067A7 (fi) | Absorptionsprodukt med snabbt fungerande absorberande innedel i flera skikt | |
| FI932957L (fi) | Glasfiberfoerstaerkt propenylpolymerkomposition | |
| FI931964L (fi) | Bryningskomposition | |
| MX9101248A (es) | Composicion adhesiva | |
| DE69211156D1 (de) | Sonnenschutzzusammensetzung | |
| FI933467L (fi) | Komposition | |
| DE69222987D1 (de) | Photopolymerisierbare zusammensetzung | |
| BR8906787A (pt) | Composicao | |
| FI924643A7 (fi) | Braenslekomposition | |
| DE69206803D1 (de) | Zusammensetzungsvorrichtung | |
| DE69208580D1 (de) | Photopolymerisierbare Zusammensetzung | |
| BR8902491A (pt) | Composicao | |
| DE69225104D1 (de) | PCT-Zusammensetzung | |
| FI922697L (fi) | Komposition foer avlaegsnande av polymerbelaeggningar | |
| BR8907528A (pt) | Composicao crio-protetora | |
| TR26099A (tr) | Islah edilmis pestisid terkip |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application lapsed |